An observational study in Cochlear Hearing Loss, sponsored by Advanced Bionics AG. Recruiting at 1 site in Germany. Per ClinicalTrials.gov, last updated 2026-11-05.
Sponsored by Advanced Bionics AG (part of Sonova AG) · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 28 studies in Hearing Loss, Sensorineural by Sonova AG — 4 open to participants now, 4 under way, none of them phase 3. Hearing Loss, Sensorineural · Sonova AG.
Among the 28 studies in Hearing Loss, Sensorineural by Sonova AG, this one is one of 3 that started in 2024, is one of 7 observational ones, and was the 25th registered.
348 studies on the registry are indexed under Hearing Loss, Sensorineural; 103 are open to participants now.
Browse Hearing Loss, Sensorineural studies →4 of the 28 studies in Hearing Loss, Sensorineural by Sonova AG are open now, in 8 countries. Recruiting first, the newest first:
Advanced Bionics AG · Sites in France
Ages 18+
Advanced Bionics AG · Sites in Belgium, France, Germany and 4 more countries
Ages 18+
Sonova AG · Sites in United States
Ages 18+
By country, each count listing its studies:
Of the 70 Hearing Loss, Sensorineural studies recruiting now, 39 (56%) set no upper age limit and 19 (27%) stop at 75 or younger; 26 take children under 18; 17 take healthy volunteers.
This study: all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
28 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 2 1 · Phase 3 1
First in 2015; this study’s year is marked. 3 started in 2024.
This study's planned enrollment of 200 is above the median of 70 across 86 observational studies indexed under Hearing Loss, Sensorineural.
Median enrollment 20 across the 21 interventional studies, 37 across the 7 observational. Of the 24 that completed or were terminated, 13 (54%) have results posted.
This tab as a report to print or save as PDF → With an account.
This study is registered under Advanced Bionics AG, one of the names counted as Sonova AG. Under that name alone:
Advanced Bionics AG is the lead sponsor of 12 studies on the registry; 3 are open to participants now.
2 of the studies in Hearing Loss, Sensorineural by Sonova AG that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT06894303Advanced Bionics AGEvaluation of Remote Programming of Cochlear Implants in Routine Cochlear Implant Follow-up | 2026-12 |
| NCT06268340Advanced Bionics AGHearing and Structure Preservation Via ECochG | 2026-12-31 |
Add all 2 to your calendar (.ics) → With an account.
Among the 28 studies in Hearing Loss, Sensorineural by Sonova AG, from their registry updates:
This tab as a report to print or save as PDF → With an account.
This is a retrospective study designed to collect speech perception results for HiRes Ultra CI and HiRes Ultra 3D CI users as measured in the clinical routine and to confirm the performance of these devices.
The studied population consists of all CI users implanted with a HiRes Ultra Version V2 or HiRes Ultra 3D Version V2 CI at the Medical University of Hannover in Germany (MHH).
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Unilateral or bilateral HiRes Ultra CI or HiRes Ultra 3D CI users including
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
HiRes Ultra or HiRes Ultra 3D Version V2 newly implanted on this side
HiRes Ultra or HiRes Ultra 3D Version V2 implanted following an Ultra Version V1 device failure on the same ear
Freiburger monosyllabic word recognition score in quiet in the implanted ear
Score obtained with the Freiburger Monosyllabic word test
Time frame: 12 months after device activation
Started Jan 2024 (actual). Primary completion is estimated for Dec 2027, 47 months after the start.
Since we started tracking on Sep 25, 2026, the dates moved once, on Nov 5, 2026: primary completion Dec 2025 → Dec 2027 and completion Dec 2025 → Dec 2027.
Earlier changes are on the record history on ClinicalTrials.gov ↗
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.